GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slc18a2 | decreases activity | ISO | SLC18A2 (Homo sapiens) | 6480464 | CTD | Rotenone results in decreased activity of SLC18A2 protein | PMID:25496994 | Slc18a2 | decreases expression | ISO | Slc18a2 (Rattus norvegicus) | 6480464 | CTD | Rotenone results in decreased expression of SLC18A2 mRNA; Rotenone results in decreased expression of SLC18A2 protein | PMID:18579341 PMID:26276080 PMID:28238857 PMID:28585189 | Slc18a2 | multiple interactions | ISO | Slc18a2 (Rattus norvegicus) | 6480464 | CTD | asiaticoside inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA]; Dabigatran inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA]; PQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of SLC18A2 protein] | PMID:26276080 PMID:28238857 PMID:28585189 | Slc18a2 | multiple interactions | ISO | SLC18A2 (Homo sapiens) | 6480464 | CTD | pyrazolanthrone inhibits the reaction [Rotenone results in decreased activity of SLC18A2 protein] | PMID:25496994 | |
Go Back to source page | Continue to Ontology report |